Correction: Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer

Affiliations

• ¹ Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
• ² Program in Molecular Medicine, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
• ³ School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
• ⁴ Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
• ⁵ Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.
• ⁶ Institute of Medicine, Chung Shan Medical University, 110, Sec.1, Chien-Kuo N. Road, Taichung City, 402306, Taiwan.
• ⁷ Biomedical Industry Ph.D. Program, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
• ⁸ Program in Molecular Medicine, Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
• ⁹ Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
• ¹⁰ Department of Neurosurgery, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
• ¹¹ Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
• ¹² Institute of Biomedical Sciences, Mackay Medical College, New Taipei City, Taiwan.
• ¹³ Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
• ¹⁴ Genomics Research Center, Academia Sinica, Taipei, 115, Taiwan.
• ¹⁵ Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
• ¹⁶ Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. ymchen@vghtpe.gov.tw.
• ¹⁷ School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. ymchen@vghtpe.gov.tw.
• ¹⁸ Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan. liu-hsuan@mail.cgu.edu.tw.
• ¹⁹ Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan. liu-hsuan@mail.cgu.edu.tw.
• ²⁰ Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan. liu-hsuan@mail.cgu.edu.tw.
• ²¹ Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan. liu-hsuan@mail.cgu.edu.tw.
• ²² Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. cyhuang5@nycu.edu.tw.
• ²³ Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. cyhuang5@nycu.edu.tw.
• ²⁴ Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. cyhuang5@nycu.edu.tw.